Florian Gembardt
Impact in
-
- Renin-Angiotensin System Studies
- Heart Failure Treatment and Management
-
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Papers in
-
- Renin-Angiotensin System Studies 22
- Heart Failure Treatment and Management 3
-
- Receptor Mechanisms and Signaling 15
- Co-authors
- Thomas Walther (24 shared papers)Heinz‐Peter Schultheiss (9 shared papers)Silvia Heringer‐Walther (6 shared papers)Wolf‐Eberhard Siems (7 shared papers)Carlos F. Sánchez‐Ferrer (3 shared papers)Christian Hugo (13 shared papers)Heinz‐Peter Schultheiß (3 shared papers)Anja Sterner‐Kock (3 shared papers)
- Journals
- PLoS ONE (3 papers)Journal of Hypertension (2 papers)Journal of Clinical Investigation (2 papers)European Journal of Pharmacology (2 papers)The FASEB Journal (2 papers)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Florian Gembardt
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 81
- Cardiology and Cardiovascular Medicine 847
- Endocrinology, Diabetes and Metabolism 549
- Nephrology 124
- Pharmacology 197
- Molecular Biology 599
Countries citing papers authored by Florian Gembardt
This map shows the geographic impact of Florian Gembardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Gembardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Gembardt more than expected).
Fields of papers citing papers by Florian Gembardt
This network shows the impact of papers produced by Florian Gembardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Gembardt. The network helps show where Florian Gembardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Gembardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 340 | |
| 2 | 2014 | 162 | |
| 3 | 2005 | 158 | |
| 4 | 2013 | 80 | |
| 5 | 2008 | 71 | |
| 6 | 2007 | 66 | |
| 7 | 2010 | 60 | |
| 8 | 2009 | 59 | |
| 9 | 2007 | 58 | |
| 10 | 2005 | 43 | |
| 11 | 2008 | 39 | |
| 12 | 2022 | 35 | |
| 13 | 2022 | 34 | |
| 14 | 2010 | 31 | |
| 15 | 2018 | 29 | |
| 16 | 2010 | 28 | |
| 17 | 2013 | 25 | |
| 18 | 2016 | 22 | |
| 19 | 2004 | 21 | |
| 20 | 2008 | 20 |
About Florian Gembardt
Florian Gembardt is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery and Nephrology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (22 papers), Receptor Mechanisms and Signaling (15 papers), Hormonal Regulation and Hypertension (11 papers), Heart Failure Treatment and Management (3 papers), Neuropeptides and Animal Physiology (3 papers), Diabetes Treatment and Management (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (847 citations), Endocrinology, Diabetes and Metabolism (549 citations), Nephrology (124 citations), Pharmacology (197 citations) and Molecular Biology (599 citations). Florian Gembardt has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Thomas Walther, Heinz‐Peter Schultheiss, Silvia Heringer‐Walther, Wolf‐Eberhard Siems, Carlos F. Sánchez‐Ferrer, Christian Hugo, Heinz‐Peter Schultheiß, Anja Sterner‐Kock, Arthur Christopoulos and Graeme Milligan. Their work appears in journals such as PLoS ONE, Journal of Hypertension, Journal of Clinical Investigation, European Journal of Pharmacology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.